AU2001280727A1 - Haplotypes of the adrb3 gene - Google Patents
Haplotypes of the adrb3 geneInfo
- Publication number
- AU2001280727A1 AU2001280727A1 AU2001280727A AU8072701A AU2001280727A1 AU 2001280727 A1 AU2001280727 A1 AU 2001280727A1 AU 2001280727 A AU2001280727 A AU 2001280727A AU 8072701 A AU8072701 A AU 8072701A AU 2001280727 A1 AU2001280727 A1 AU 2001280727A1
- Authority
- AU
- Australia
- Prior art keywords
- haplotypes
- adrb3 gene
- adrb3
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22008800P | 2000-07-21 | 2000-07-21 | |
PCT/US2001/023223 WO2002008425A2 (en) | 2000-07-21 | 2001-07-23 | Haplotypes of the adrb3 gene |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001280727A1 true AU2001280727A1 (en) | 2002-02-05 |
Family
ID=22822002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001280727A Abandoned AU2001280727A1 (en) | 2000-07-21 | 2001-07-23 | Haplotypes of the adrb3 gene |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001280727A1 (en) |
WO (1) | WO2002008425A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002086122A2 (en) * | 2001-03-14 | 2002-10-31 | Hybrigenics | Protein-protein interactions in adipocytes |
WO2003106652A2 (en) * | 2002-06-14 | 2003-12-24 | Cedars-Sinai Medical Center | Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
US8178294B2 (en) | 2002-06-14 | 2012-05-15 | Cedars-Sinai Medical Center | Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
CN107271675B (en) * | 2017-03-24 | 2020-06-02 | 郑猛 | Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1081401A (en) * | 1999-10-13 | 2001-04-23 | Genaissance Pharmaceuticals, Inc. | Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene |
AU2001253720A1 (en) * | 2000-04-18 | 2001-10-30 | Genaissance Pharmaceuticals, Inc. | Method and system for determining haplotypes from a collection of polymorphisms |
-
2001
- 2001-07-23 AU AU2001280727A patent/AU2001280727A1/en not_active Abandoned
- 2001-07-23 WO PCT/US2001/023223 patent/WO2002008425A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002008425A2 (en) | 2002-01-31 |
WO2002008425A3 (en) | 2003-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002211373A1 (en) | Haplotypes of the por gene | |
AU2001276919A1 (en) | Haplotypes of the mmp13 gene | |
AU2001280727A1 (en) | Haplotypes of the adrb3 gene | |
AU2001259595A1 (en) | Haplotypes of the crybb1 gene | |
AU2001286949A1 (en) | Haplotypes of the bf gene | |
AU2001284680A1 (en) | Haplotypes of the alas2 gene | |
AU2001290603A1 (en) | Haplotypes of the or11a1 gene | |
AU2001255330A1 (en) | Haplotypes of the akr1b1 gene | |
AU2001264719A1 (en) | Haplotypes of the aanat gene | |
AU2002228618A1 (en) | Haplotypes of the lipe gene | |
AU2001249650A1 (en) | Haplotypes of the chrnb3 gene | |
AU2002227177A1 (en) | Haplotypes of the scya21 gene | |
AU2002245073A1 (en) | Haplotypes of the f2rli gene | |
AU2001274995A1 (en) | Haplotypes of the rlbp1 gene | |
AU2002213185A1 (en) | Haplotypes of the chrm5 gene | |
AU2001292815A1 (en) | Haplotypes of the scya8 gene | |
AU2001286644A1 (en) | Haplotypes of the gng7 gene | |
AU2001273117A1 (en) | Haplotypes of the appbp1 gene | |
AU2001253367A1 (en) | Haplotypes of the apoc1 gene | |
AU2001294586A1 (en) | Haplotypes of the htr5a gene | |
AU2001255317A1 (en) | Haplotypes of the ache gene | |
AU2001270296A1 (en) | Haplotypes of the mc2r gene | |
AU2001259081A1 (en) | Haplotypes of the ghrhr gene | |
AU2002239511A1 (en) | Haplotypes of the gsr gene | |
AU2001286887A1 (en) | Haplotypes of the agtr1 gene |